ON-Q PAIN PUMP
Report
- Report Number
- 2026095-2012-00404
- Event Type
- Injury
- Date Received
- January 9, 2013
- Date of Event
- June 26, 2008
- Report Date
- December 11, 2012
- Manufacturer
- I-FLOW LLC
- Product Code
- MEB
- PMA / PMN Number
- K063530
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TX, US
- Reporter Occupation
- NOT APPLICABLE
Narratives
METHOD: NO PRODUCT WAS RETURNED FOR EVAL AND INVESTIGATION. THE LOT NUMBER WAS NOT PROVIDED, THEREFORE THE DEVICE HISTORY RECORDS COULD NOT BE REVIEWED. RESULTS: THE INFO CONTAINED IS FROM LEGAL DOCUMENTS SERVED ON I-FLOW LLC. THE COMPLAINT WAS OPENED SO THAT A MEDICAL DEVICE REPORT (MDR) CAN BE FILED WITH THE US FOOD AND DRUG ADMINISTRATION. NO FURTHER INVESTIGATION WILL BE CONDUCTED. CONCLUSION: AS THIS COMPLAINT WAS CREATED FROM A LAWSUIT SERVED ON I-FLOW, NO CUSTOMER CONTACT CAN BE MADE AT THIS TIME DUE TO THE PENDING LITIGATION. AS OF 11/09/2006, I-FLOW HAS UPDATED ITS ON-Q PUMP DIRECTIONS FOR USE (DFU), TO INCLUDE THE FOLLOWING IN THE WARNINGS SECTION: "AVOID PLACING THE CATHETER IN JOINT SPACES. ALTHOUGH THERE IS NO DEFINITIVE ESTABLISHED CAUSAL RELATIONSHIP, SOME LITERATURE HAS SHOWN POSSIBLE ASSOCIATION BETWEEN CONTINUOUS INTRA-ARTICULAR INFUSIONS (PARTICULARLY WITH BUPIVACAINE) AND THE SUBSEQUENT DEVELOPMENT OF CHONDROLYSIS." (DFU 1307011). ON 08/08/2007, I-FLOW HAS ALSO PREPARED A TECHNICAL BULLETIN ENTITLED "WHAT WE KNOW ABOUT CHONDROLYSIS TODAY". (1303722, REV. E).
DRUG/DILUENT: MARCAINE 0.5%. FILL VOLUME: 50CC VIAL X3. FLOW RATE: 2ML/HR. PROCEDURE: LEFT SHOULDER ARTHROSCOPY WITH ROTATOR CUFF REPAIR, AC JOINT RESECTION AND ACROMIOPLASTY. CATHPLACE: UNK. PT ALLEGES CARTILAGE DAMAGE IN LEFT SHOULDER FOLLOWING PLACEMENT OF AN ON-Q PAIN PUMP, AFTER SURGERY ON (B)(6) 2008.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 12350 | ON-Q PAIN PUMP | ELASTOMERIC PUMP | MEB | I-FLOW LLC | PM012/PM012-A | UNK |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 52 YR | Other |